Wednesday, September 21, 2016 5:42:58 PM
Volume Weighted Average Price
$0.763 ... Sep 21, 2016
$0.756 ... Sep 20, 2016
$0.734 ... Sep 19, 2016
$0.714 ... Sep 16, 2016
$0.712 ... Sep 15, 2016
$0.722 ... Sep 14, 2016
$0.704 ... Sep 13, 2016
$0.715 ... Sep 12, 2016
$0.745 ... Sep 09, 2016
$0.687 ... Sep 08, 2016
$0.647 ... Sep 07, 2016
$0.624 ... Sep 06, 2016
$0.626 ... Sep 02, 2016
$0.617 ... Sep 01, 2016
$0.607 ... Aug 31, 2016
$0.604 ... Aug 30, 2016
$0.622 ... Aug 29, 2016
$0.618 ... Aug 26, 2016
$0.584 ... Aug 25, 2016 << Lowest Avg Price in 8 months
$0.586 ... Aug 24, 2016
$0.591 ... Aug 23, 2016
$0.590 ... Aug 22, 2016
$0.596 ... Aug 19, 2016
$0.621 ... Aug 18, 2016
$0.622 ... Aug 17, 2016
$0.597 ... Aug 16, 2016
$0.616 ... Aug 15, 2016
$0.654 ... Aug 12, 2016
$0.627 ... Aug 11, 2016
$0.607 ... Aug 10, 2016
$0.598 ... Aug 09, 2016
$0.611 ... Aug 08, 2016
$0.622 ... Aug 05, 2016
$0.616 ... Aug 04, 2016
$0.614 ... Aug 03, 2016
$0.610 ... Aug 02, 2016
$0.616 ... Aug 01, 2016
$0.616 ... Jul 29, 2016
$0.615 ... Jul 28, 2016
$0.618 ... Jul 27, 2016
$0.615 ... Jul 26, 2016
$0.623 ... Jul 25, 2016
$0.637 ... Jul 22, 2016
$0.654 ... Jul 21, 2016
$0.656 ... Jul 20, 2016
$0.637 ... Jul 19, 2016
$0.615 ... Jul 18, 2016
$0.620 ... Jul 15, 2016
$0.625 ... Jul 14, 2016
$0.622 ... Jul 13, 2016
$0.626 ... Jul 12, 2016
$0.632 ... Jul 11, 2016
$0.635 ... Jul 08, 2016
$0.652 ... Jul 07, 2016
$0.640 ... Jul 06, 2016
$0.624 ... Jul 05, 2016
$0.631 ... Jul 01, 2016
$0.640 ... Jun 30, 2016
$0.637 ... Jun 29, 2016
$0.661 ... Jun 28, 2016
$0.628 ... Jun 27, 2016
$0.666 ... Jun 24, 2016
$0.706 ... Jun 23, 2016
$0.709 ... Jun 22, 2016
$0.708 ... Jun 21, 2016
$0.707 ... Jun 20, 2016
$0.744 ... Jun 17, 2016
$0.734 ... Jun 16, 2016
$0.728 ... Jun 15, 2016
$0.734 ... Jun 14, 2016
$0.759 ... Jun 13, 2016
$0.788 ... Jun 10, 2016
$0.768 ... Jun 09, 2016
$0.771 ... Jun 08, 2016
$0.795 ... Jun 07, 2016
Recent SNGX News
- Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting • PR Newswire (US) • 05/24/2024 11:30:00 AM
- Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split • PR Newswire (US) • 05/23/2024 11:30:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/22/2024 08:05:06 PM
- PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon • GlobeNewswire Inc. • 05/21/2024 04:35:16 PM
- SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference • PR Newswire (US) • 05/21/2024 11:30:00 AM
- Soligenix Encourages Stockholders to Vote Prior to Annual Meeting • PR Newswire (US) • 05/20/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:25:40 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/17/2024 08:09:20 PM
- Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice • PR Newswire (US) • 05/16/2024 11:30:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/15/2024 08:05:38 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/10/2024 08:16:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:05:50 PM
- Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results • PR Newswire (US) • 05/10/2024 11:30:00 AM
- Soligenix to Present at Upcoming Conferences • PR Newswire (US) • 05/06/2024 11:30:00 AM
- Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa • PR Newswire (US) • 04/25/2024 11:30:00 AM
- Soligenix Announces Pricing of $4.75 Million Public Offering • PR Newswire (US) • 04/18/2024 12:30:00 PM
- FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection • PR Newswire (US) • 04/15/2024 11:30:00 AM
- FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection • PR Newswire (US) • 04/11/2024 11:30:00 AM
- Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agency • PR Newswire (US) • 04/03/2024 11:30:00 AM
- Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results • PR Newswire (US) • 03/15/2024 11:30:00 AM
- Soligenix Announces Formation of Behçet's Disease Medical Advisory Board • PR Newswire (US) • 02/08/2024 12:30:00 PM
- Soligenix to Present at The Microcap Conference • PR Newswire (US) • 01/25/2024 12:30:00 PM
- FDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease • PR Newswire (US) • 01/08/2024 12:30:00 PM
- Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis • PR Newswire (US) • 01/04/2024 12:30:00 PM
- Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses • PR Newswire (US) • 01/02/2024 12:30:00 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM